NCT03209648View on ClinicalTrials.gov

A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

August 23, 2017

Study Completion Date

August 31, 2017

Conditions
Healthy Participants
Interventions
DRUG

Debio 1450

Debio 1450, 40 mg capsule.

DRUG

Itraconazole

Itraconazole, 20 mL of 10 mg/mL solution.

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd., Leeds

Sponsors
All Listed Sponsors
lead

Debiopharm International SA

INDUSTRY